Aprameya Engineering Limited (NSE SME)
Jul 25, 2024 - Jul 29, 2024
| Price | ₹56 - ₹58 |
| Premium | ₹23 |
|---|---|
| Lot size | 2000 |
| Allotment | Jul 30, 2024 |
| Listing | Aug 1, 2024 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 2000 | 116000 | 838 |
| HNI | 2 | 4000 | 232000 | 359 |
Last updated on 29-Jul-2024 15:44:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 958000 | 86498000 | 90.29 |
| NIB | 718000 | 241268000 | 336.03 |
| RETAIL | 1676000 | 278932000 | 166.43 |
| Total | 3352000 | 606698000 | 181 |
| Retail Apps | 139466 | © IPO Premium | |
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹26.16 | @8% ₹29.9 | @9% ₹33.64 | @10% ₹37.38 | @11% ₹41.12 | @12% ₹44.85 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 33.25% | 1676000 |
| NII (HNI) | 14.25% | 718000 |
| Anchor | 28.45% | 1434000 |
| QIB | 19.01% | 958000 |
| Market Maker | 5.04% | 254000 |
| Total | 100.00% | 5040000 |
Incorporated in September 2003, Aprameya Engineering Limited specializes in the installation and maintenance of Intensive Care Units (ICUs), Neonatal Intensive Care Units (NICUs), Pediatric Intensive Care Units (PICUs), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers, offering these services on a turnkey basis. The company also supplies high-value healthcare and diagnostic equipment to both private and government hospitals. Since 2020, Aprameya Engineering has installed around 2000 critical care beds and modular operation theatres, primarily in Rajasthan. Their product range includes a variety of medical equipment such as Electrosurgical Generators, LED Surgery Lights, ICU Ventilation Systems, and Anesthesia Workstations. The company operates four warehouses in Ahmedabad and, as of August 31, 2023, employs 44 permanent staff members dedicated to business operations, marketing, and accounting functions.
Aprameya Engineering IPO Details
| Total Issue Size | 5,040,000 shares (aggregating up to ₹29.23 Cr) |
| Fresh Issue | 5,040,000 shares (aggregating up to ₹29.23 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 14,000,000 |
| Share holding post issue | 19,040,000 |
| Market Maker portion | 254,000 shares |
Key Performance Indicators
| KPI | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|
| ROE | 15.97% | 182.04% | 28.97% |
| ROCE | 9.60% | 88.78% | 46.31% |
| RONW | 14.79% | 114.38% | 27.36% |
| EPS (basic) | 2.47 | 11.87 | 0.73 |
P/E Pre IPO | 15.12 | ||
P/E Post IPO | 20.57 |
Financial Statement (restated)
| Period Ended | Mar-24 | Mar-23 | Mar-22 | Mar-21 |
|---|---|---|---|---|
| Assets | 7,560.42 | 6,189.03 | 4,870.84 | 1,087.00 |
| Revenue | 6,562.22 | 7,833.35 | 20,026.16 | 2,601.23 |
| Profit After Tax | 345.67 | 536.92 | 1,661.91 | 102.04 |
| Net Worth | 2,336.76 | 1,992.49 | 1,452.94 | 372.96 |
| Reserves and Surplus | 936.76 | 592.49 | 752.94 | |
| Total Borrowing | 4,204.83 | 2,873.95 | 1,368.28 | 148.27 |
| Amount in Lakhs | ||||
Hem Securities Limited
904, A wing, 9th Floor,
Naman Midtown, Senapati bapat marg,
Elphinstone road, Lower Parel
Website: https://www.hemsecurities.com
Email: ipoinfo@hemonline.com
Phone: +91 22 49060000
Rapid Business Growth in Healthcare Infrastructure: The Company is experiencing rapid growth, particularly in setting up healthcare infrastructure, which strengthens its market position.
Proven Execution Capabilities: The Company has a strong track record in setting up ICUs, NICUs, PICUs, and Operation Theatres, demonstrating its expertise and reliability in complex projects.
Strong Supplier Relationships: The Company has firm arrangements with numerous medical equipment suppliers and manufacturers, ensuring access to high-quality resources and timely project completion.
Dependency on Key Customers: The loss or significant reduction in demand from key customers can materially and adversely impact the company's business and financial performance.
Competitive Bidding and Uncertain Contracts: The Company’s reliance on competitive bidding processes for work orders, especially from government agencies with stringent terms, poses a risk to future contract awards and can negatively affect business growth and financial results.
Healthcare Infrastructure Spending: The Company’s business and profitability are heavily dependent on customer spending in the healthcare infrastructure industry. Any decline in this spending in India could adversely affect their operations.
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: aprameya.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html